Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care AG & Co. KGaA (FMS) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
fms · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Fresenius Medical Care AG & Co. KGaA (FMS) measures how much investors pay for each dollar of the company's trailing earnings. FMS's current PE ratio of 11.06x is calculated by dividing its stock price of $21.82 by its TTM earnings per share of $3.43. −53.8% discount vs 5Y avg 23.9x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 20 fiscal years · Front-end computedMinQ1 · 25%21.3x
MedianQ3 · 75%34.5x
Max
At 11.06x, FMS's current P/E is lower than in 5% of its annual fiscal year readings over the past 20 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Care Facilities · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Fresenius Medical Care AG & Co. KGaAYou FMS | $11.7B | 11.06x | -59.9% | $3.43 |
 DaVita Inc. DVA | $12.4B | 13.10x | -52.5% | $8.67 |
 Encompass Health Corporation EHC | $10.1B | 18.84x | -31.7% | $5.63 |
 Hologic, Inc. HOLX | $17.0B | 26.99x | -2.2% | $2.49 |
 ICON Public Limited Company ICLR | $11.6B | 62.31x | +125.8% | $2.92 |
 Royalty Pharma plc RPRX | $23.9B | 21.65x | -21.6% | $1.79 |
 Smith & Nephew plc SNN | $12.9B | 22.70x | -17.7% | $1.45 |
Industry Average 6 peers with valid PE | — | 27.60x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | 12.07x | $1.68 | -49.5% | |
2024-12-31 FY2024 | 23.89x | $0.91 | +5.6% | |
2023-12-31 FY2023 | 22.62x | $0.85 | -14.9% | |
2022-12-31 FY2022 | 26.58x | $0.57 | -23.0% | |
2021-12-31 FY2021 | 34.51x | $0.83 | +33.0% | |
2020-12-31 FY2020 | 25.94x | $1.31 | +6.7% | |
2019-12-31 FY2019 | 24.32x | $1.35 | +177.7% | |
2018-12-31 FY2018 | 8.76x | $3.23 | -58.2% | |
2017-12-31 FY2017 | 20.96x | $2.08 | +0.7% | |
2016-12-31 FY2016 | 20.80x | $1.93 | -16.7% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Fresenius Medical Care AG & Co. KGaA (FMS) measures how much investors pay for each dollar of the company's trailing earnings. FMS's current PE ratio of 11.06x is calculated by dividing its stock price of $21.82 by its TTM earnings per share of $3.43.
Frequently asked questions
FMS pe ratio · 6 questionsFMS's current PE ratio is 11.06x as of 2026-06-08, based on a stock price of $21.82 and TTM EPS of $3.43. Data sourced from Financial Modeling Prep via FMS's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Fresenius Medical Care AG & Co. KGaA SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08